menu search

Syfovre® (pegcetacoplan injection) continued to demonstrate increasing treatment effects over 3 years in patients with geographic atrophy (ga)

SYFOVRE reduced nonsubfoveal GA lesion growth by over 40% (monthly) in Year 3 compared to projected sham in the GALE extension study Well-demonstrated...

November 4, 2023, 5:37 pm

Wave life sciences third quarter 2023 financial results scheduled for november 9, 2023

CAMBRIDGE, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed to delive...

November 3, 2023, 8:05 pm

New preliminary clinical data on potential of opus aav-based gene therapy for rare inherited retinal disease to be presented at the american academy of ophthalmology annual conference 2023

Data to be presented as part of gene augmentation therapy presentation RALEIGH, N.C., Nov. 03, 2023 (GLOBE NEWSWIRE) — Opus Genetics, a patient-focu...

November 3, 2023, 7:43 pm

Davita (dva) to report q3 earnings: what's in the offing?

Improvement in U.S. dialysis treatments per day and cost-saving initiatives are likely to have boosted ...

November 3, 2023, 1:32 pm

Bruise treatment market size to reach usd 444 million by 2031, at a 3.5 % cagr | by tmr

Emerging trends in regenerative medicine and stem cell therapies are expected to offer innovative solutions for bruise ...

November 3, 2023, 12:30 pm

Ovid therapeutics reports third quarter 2023 financial results and corporate updates

Received a $30 million payment from Ligand for the sale of a 13% interest in the potential future royalties and milestone payments owed to Ovid for so...

November 3, 2023, 12:00 pm

Centers for medicare & medicaid services establishes new category i cpt® add-on code for coronary ivl

New Add-On Code Goes Into Effect January 1, 2024 SANTA CLARA, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pio...

November 3, 2023, 12:00 pm

Turnstone biologics presents preclinical data highlighting potential for selected tumor-infiltrating lymphocyte (til) therapy in solid tumors at the 2023 society for immunotherapy of cancer (sitc) ann

Presentations showcase Turnstone’s novel Selected TIL programs which are designed to selectively expand the most potent tumor-reactive T cells for <...

November 3, 2023, 10:00 am

Chemical injection pump market rising at 7.4% cagr to hit us$ 70 billion by 2033: fact.mr report

Chemical injection pump suppliers are dedicating their efforts to the advancement of centrifugal pumps tailored for the water ...

November 3, 2023, 9:00 am

Should you still buy the nasdaq's best-performing october stocks?

Structure Therapeutics' weight-loss drug candidate is attracting attention over excitement about obesity treat...

November 3, 2023, 5:20 am

Poolbeg's lead asset to be in the spotlight at leading medical conference

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) said the potential of its lead asset will be discussed at a leading medical conference in December. A poste...

November 3, 2023, 3:32 am

The north america rare disease summit focused on the need for centralized data to improve the lives of 30 million people living with rare conditions

Stakeholders debate at the North America Rare Disease Summit on the challenges regarding treatment appr...

November 2, 2023, 7:51 pm

Regenxbio: biotech to watch with 2 possible accelerated approval pathways

Regenxbio Inc. is making progress in its pipeline, aiming to have five gene therapies in late-stage testing or approved by 2025. The company's lead ca...

November 2, 2023, 5:33 pm

3 business development companies yielding over 7%

Business development companies, or BDCs, typically have high dividend yields, as they are required to distribute nearly all of their earnings to share...

November 2, 2023, 3:02 pm

Weight loss drug wegovy sales fuel novo nordisk stock performance

Novo Nordisk (NVO) stock rose after the pharmaceutical company reported strong third-quarter sales growth, fueled by its popular weight-loss drug, Weg...

November 2, 2023, 2:58 pm

Futura medical wins new product award from boots

Futura Medical's Eroxon erectile dysfunction treatment won the "New Product of the Year, Healthcare" c...

November 2, 2023, 12:15 pm

Kura oncology and mirati therapeutics enter into clinical collaboration and supply agreement to evaluate ko-2806 and adagrasib in krasᴳ¹²ᶜ-mutated nsclc

– Ongoing Phase 1 dose-escalation trial of KO-2806 (FIT-001) expected to begin dosing patients in combination with adagrasib by mid-2024 – SAN DIE...

November 2, 2023, 11:30 am

Autolus therapeutics reports third quarter 2023 financial results and business updates

Obe-cel, a potentially transformational treatment for relapsed/refractory (r/r) adult B-cell Acute Lymp...

November 2, 2023, 11:11 am

Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato

BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today announced that new data from an additional 52-w...

November 2, 2023, 9:09 am


Search within

Pages Search Results: